angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- has been researched along with malondialdehyde in 1 studies
| Studies (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-) | Trials (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-) | Recent Studies (post-2010) (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-) | Studies (malondialdehyde) | Trials (malondialdehyde) | Recent Studies (post-2010) (malondialdehyde) |
|---|---|---|---|---|---|
| 311 | 5 | 64 | 27,849 | 1,405 | 13,922 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, XZ; Li, XH; Lin, QX; Lin, SG; Xiao, DZ; Yu, XY; Zhong, JC | 1 |
1 other study(ies) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and malondialdehyde
| Article | Year |
|---|---|
Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Cells, Cultured; Cloning, Molecular; Humans; Insulin; Insulin Resistance; Macrophage Migration-Inhibitory Factors; Malondialdehyde; NADPH Oxidases; Peptidyl-Dipeptidase A; Proto-Oncogene Proteins c-akt; RNA, Messenger; Signal Transduction | 2008 |